EC signs 2nd COVID-19 vaccine contract

Added On September 19, 2020

According to the Commission's statement, the contract is signed with France's Sanofi and GlaxoSmithKline (GSK) of Britain. It will allow all European Union member states to purchase up to 300 million doses of the Sanofi-GSK vaccine. Moreover, member states may donate reserved doses to lower and middle-income countries. Sanofi and GSK aim to have the vaccine available by the second half of 2021. The Commission had already signed a contract in August with British-Swedish pharmaceutical firm AstraZeneca for COVID-19 vaccines. According to the World Health Organization, as of Sept. 17, there had been 182 COVID-19 candidate vaccines being developed worldwide, and 36 of them were in clinical trials. Several vaccines from the U.S., Britain, China, and Germany are in phase-3 trials.